Interheteroaryl 7-oxabicyclic (2.2.1)heptane oxazoles as prostaglandin F2alpha antagonists

Details for Australian Patent Application No. 2001290692 (hide)

Owner Allergan, Inc.

Inventors Donde, Yariv; Burk, Robert M

Agent Davies Collison Cave

Pub. Number AU-B-2001290692

PCT Pub. Number WO02/22620

Priority 09/677,372 14.09.00 US

Filing date 7 September 2001

Wipo publication date 26 March 2002

Acceptance publication date 20 July 2006

International Classifications

C07D 493/08 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

Event Publications

20 July 2006 Application Accepted

  Published as AU-B-2001290692

24 August 2006 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 04 Aug 2006. Address for service in Australia - Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000 2002

23 November 2006 Standard Patent Sealed

11 January 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 04 Aug 2006 2002

1 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001290693-Method and apparatus for XML data storage, query rewrites, visualization, mapping and references

2001290691